“Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy analysis of 6-substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester derivatives”, Int. J. Pharm. Sci. Drug Res., vol. 16, no. 3, pp. 378–386, May 2024, doi: 10.25004/IJPSDR.2024.160309.